DUBLIN — April 2, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral...
Art Pappas to participate on panel, “Investing in Neurotech” at Neurotech Investing and Partnering Conference in Boston, MA
News | 05. 19. 2010
© 2020 Pappas Capital, LLC. ALL RIGHTS RESERVED.